메뉴 건너뛰기




Volumn 57, Issue 10, 2016, Pages 1529-1534

Optimal acquisition time window and simplified quantification of dopamine transporter availability using 18F-FE-PE2I in healthy controls and Parkinson disease patients

Author keywords

Dopamine transporter; FE PE2I; Parkinson disease; PET; Quantification

Indexed keywords

DOPAMINE TRANSPORTER; FLUORINE 18; N (3 IODOPROP 2 ENYL) 2BETA CARBOFLUOROETHOXY 3BETA (4' METHYLPHENYL)NORTROPANE F 18; TRACER; UNCLASSIFIED DRUG; (E)-N-(3-IODOPROP-2-ENYL)-2BETA-CARBOFLUOROETHOXY-3BETA-(4'-METHYL-PHENYL) NORTROPANE; NORTROPANE DERIVATIVE;

EID: 84991406541     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.115.171231     Document Type: Article
Times cited : (21)

References (22)
  • 1
    • 70349779416 scopus 로고    scopus 로고
    • 11C]PE2I in patients with schizophrenia: A positron emission tomography study of dopamine transporter
    • 11C]PE2I in patients with schizophrenia: a positron emission tomography study of dopamine transporter. J Psychiatr Res. 2009;43:1219-1223.
    • (2009) J Psychiatr Res. , vol.43 , pp. 1219-1223
    • Arakawa, R.1    Ichimiya, T.2    Ito, H.3
  • 2
    • 0030897476 scopus 로고    scopus 로고
    • PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease
    • Ginovart N, Lundin A, Farde L, et al. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain. 1997;120:503-514.
    • (1997) Brain , vol.120 , pp. 503-514
    • Ginovart, N.1    Lundin, A.2    Farde, L.3
  • 3
    • 0344442712 scopus 로고    scopus 로고
    • Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR
    • Hurley MJ, Mash DC, Jenner P. Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR. Eur J Neurosci. 2003;18:2668-2672.
    • (2003) Eur J Neurosci , vol.18 , pp. 2668-2672
    • Hurley, M.J.1    Mash, D.C.2    Jenner, P.3
  • 4
    • 13244287886 scopus 로고    scopus 로고
    • Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity
    • Jucaite A, Fernell E, Halldin C, Forssberg H, Farde L. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry. 2005;57:229-238.
    • (2005) Biol Psychiatry , vol.57 , pp. 229-238
    • Jucaite, A.1    Fernell, E.2    Halldin, C.3    Forssberg, H.4    Farde, L.5
  • 5
    • 73849108267 scopus 로고    scopus 로고
    • Brain serotonin and dopamine transporter bindings in adults with high-functioning autism
    • Nakamura K, Sekine Y, Ouchi Y, et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry. 2010;67:59-68.
    • (2010) Arch Gen Psychiatry , vol.67 , pp. 59-68
    • Nakamura, K.1    Sekine, Y.2    Ouchi, Y.3
  • 6
    • 2342555065 scopus 로고    scopus 로고
    • Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: A comparison
    • Walker Z, Costa DC, Walker RW, et al. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison. Neurology. 2004;62:1568-1572.
    • (2004) Neurology , vol.62 , pp. 1568-1572
    • Walker, Z.1    Costa, D.C.2    Walker, R.W.3
  • 7
    • 84861325358 scopus 로고    scopus 로고
    • The molecular basis of dopaminergic brain imaging in Parkinson's disease
    • Seibyl J, Russell D, Jennings D, Marek K. The molecular basis of dopaminergic brain imaging in Parkinson's disease. Q J Nucl Med Mol Imaging. 2012;56:4-16.
    • (2012) Q J Nucl Med Mol Imaging , vol.56 , pp. 4-16
    • Seibyl, J.1    Russell, D.2    Jennings, D.3    Marek, K.4
  • 8
    • 0030781707 scopus 로고    scopus 로고
    • Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra
    • Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol. 1997;388:211-227.
    • (1997) J Comp Neurol. , vol.388 , pp. 211-227
    • Hersch, S.M.1    Yi, H.2    Heilman, C.J.3    Edwards, R.H.4    Levey, A.I.5
  • 9
    • 0030031457 scopus 로고    scopus 로고
    • The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons
    • Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci. 1996;16:436-447.
    • (1996) J Neurosci , vol.16 , pp. 436-447
    • Nirenberg, M.J.1    Vaughan, R.A.2    Uhl, G.R.3    Kuhar, M.J.4    Pickel, V.M.5
  • 10
    • 81055125527 scopus 로고    scopus 로고
    • The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration
    • Cummings JL, Henchcliffe C, Schaier S, Simuni T, Waxman A, Kemp P. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain. 2011;134:3146-3166.
    • (2011) Brain , vol.134 , pp. 3146-3166
    • Cummings, J.L.1    Henchcliffe, C.2    Schaier, S.3    Simuni, T.4    Waxman, A.5    Kemp, P.6
  • 11
    • 77957100232 scopus 로고    scopus 로고
    • Molecular imaging of the dopamine transporter
    • Varrone A, Halldin C. Molecular imaging of the dopamine transporter. J Nucl Med. 2010;51:1331-1334.
    • (2010) J Nucl Med. , vol.51 , pp. 1331-1334
    • Varrone, A.1    Halldin, C.2
  • 12
    • 84861325008 scopus 로고    scopus 로고
    • New developments of dopaminergic imaging in Parkinson's disease
    • Varrone A, Halldin C. New developments of dopaminergic imaging in Parkinson's disease. Q J Nucl Med Mol Imaging. 2012;56:68-82.
    • (2012) Q J Nucl Med Mol Imaging , vol.56 , pp. 68-82
    • Varrone, A.1    Halldin, C.2
  • 14
    • 70349123080 scopus 로고    scopus 로고
    • 18F]FE-PE2I, a new dopamine transporter PET radioligand
    • 18F]FE-PE2I, a new dopamine transporter PET radioligand. Synapse. 2009;63:871-880.
    • (2009) Synapse , vol.63 , pp. 871-880
    • Varrone, A.1    Steiger, C.2    Schou, M.3
  • 19
    • 84929484781 scopus 로고    scopus 로고
    • 18F-(E)-N-(3-iodoprop-2-enyl)-2β-carbofluoroethoxy-3β-(4′-methyl-phenyl) nortropane binding to the dopamine transporter in Parkinson disease
    • 18F-(E)-N-(3-iodoprop-2-enyl)-2β-carbofluoroethoxy-3β-(4′-methyl-phenyl) nortropane binding to the dopamine transporter in Parkinson disease. J Nucl Med. 2015;56:714-720.
    • (2015) J Nucl Med. , vol.56 , pp. 714-720
    • Fazio, P.1    Svenningsson, P.2    Forsberg, A.3
  • 20
    • 70350547987 scopus 로고    scopus 로고
    • Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT
    • Varrone A, Sjoholm N, Eriksson L, Gulyas B, Halldin C, Farde L. Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. Eur J Nucl Med Mol Imaging. 2009;36:1639-1650.
    • (2009) Eur J Nucl Med Mol Imaging , vol.36 , pp. 1639-1650
    • Varrone, A.1    Sjoholm, N.2    Eriksson, L.3    Gulyas, B.4    Halldin, C.5    Farde, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.